The Institute of Biomedical Research Corp. (MRES.PK) Is Proud to Announce that it has updated corporative website

Podgorica, Montenegro – (August, 2015) –The Institute of Biomedical Research Corp. (OTC Pink:MRES)  has announced today to have updated its corporative website.

Dr. Drasko Pekovic, president and CEO of the Institute said: “Updated website of the Institute shows a significant progress that the company has achieved in relatively short period of its establishment, in the field of professional activities, as well as in the domain of research and development of new biomedical products and technologies. In other word the Institute has accepted all challenges that came on its way.

In additional to its concept and professional orientation, the rapid development of the Institute in Podgorica-Montenegro proves that the institution is located in the right place and at the appropriate socio-economical timing of the country, which will favour further opportunities for institutional development and financial strengthening.

The opening of the representative office in Montreal (Canada) has been very encouraging experience and helpful in the establishment of scientific and business collaboration and the introducing of new developed biomedical products on the North American market.

The team of the Institute has reached professional maturity and cohesion, and focuses on further scientific and technical diversification. The starting point of all its achievements was motivated and passionate desire to assure leadership of the Institute in the South-Eastern European region.

All these important advances of the Institute are reflected in continuous very encouraging corporative financial strengthening and give us inspiration for continuation of our leadership”.

 

[Back to Top]
 

The Institute of Biomedical Research Corp. (MRES.PK) Is Proud to Announce that Dr. D. Drasko Pekovic, its President and CEO is Appointed Editor of the International Scientific Journal EC Microbiology

Podgorica, Montenegro – (Monday, August 17, 2015) –The Institute of Biomedical Research Corp. (OTC Pink:MRES)  has announced today that Dr. Drasko Pekovic, president and CEO of the Institute has been appointed the Editor of the International  Scientific Journal EC Microbiology.

Dr. Drasko Pekovic, president and CEO of the Institute said: “My appointment as the Editor of valuable international scientific Journal EC Microbiology is a challenging recognition of my scientific career as well as an acknowledgement of current scientific activities of the Institute worldwide. My appointment will facilitate the scientific collaboration of the Institute with leading scientists, scientific groups and institutions throughout the world.

[Back to Top]
 

The Institute of Biomedical Research Corp. (MRES.PK) has Developed Standardised Method for Decontamination of Microbiologically Contaminated Buildings

Podgorica, Montenegro – ( Monday, August 10, 2015) –The Institute of Biomedical Research Corp. (OTC Pink:MRES)  has announced today that it has developed a new method of decontamination of microbiologically contaminated building which has proven its efficacy over relatively long period of time of its field application. The method is now standardised and employed in Canada and Eastern European countries.

Dr Pekovic, President and CEO of the Institute said: “The new methodology has been developed over relatively long period of time in collaboration with our scientists and technical team on the field. The technique has shown important efficacy, and as a procedure, is now standardised. The technique of decontamination of microbiologically contaminated building has received important interest from residential, commercial and industrial sectors in Canada, and also in Eastern European countries”.

[Back to Top]
 

The Institute of Biomedical Research Corp.(MRES.PK) to take over Montenegro’s National Testing and Research Institution “Center for Ecological Studies

PODGORICA, MONTENEGRO–(Marketwired – June 16,2014) – The Institute of Biomedical Research Corp. (OTC Pink: MRES) announced today that it is in the final stages of negotiations with the Government of Montenegro to take over the “Center for Ecological Studies”, the largest national scientific and analytical institution and the only one of its kind in the Balkans Peninsula. The “Center for Ecological Studies” is a reference testing and scientific institution, well established for the past 20 years and employs over 100 scientists and analysts.

Dr. Drasko Pekovic, President and CEO of the Institute said “This merge is a logical step in the advancement of scientific and technical capabilities in the region in which the Government of Montenegro and its neighboring countries must facilitate the numerous scientific, technical and standardization challenges imposed by the emerging European Union requirements”.

[Back to Top]
 

The Institute of Biomedical Research Corp. (MRES.PK) has Established a Representative Office in Montreal, Canada

The Institute of Biomedical Research Corp. (MRES.PK) has Established a Representative Office in Montreal, Canada

Podgorica, Montenegro  – (May, 2014 –The Institute of Biomedical Research Corp. (OTC Pink:MRES)  has announced today that it has established a representative office in Montreal, Canada, which is in operational state in the field of scientific research and commercial activities.

Dr. Drasko Pekovic, president and CEO of the Institute said: “The establishment of the representative office of the Institute in Montreal will be helpful in development of scientific and technological collaboration with new partners in North America, as well as for marketing and commercialisation of Institutes’ new products and technologies.”

[Back to Top]
 

Neuro-Biotech Corp. (MRES.PK) Performs Reverse Split and name change to The Institute of Biomedical Research Corp.

PODGORICA, MONTENEGRO–(Marketwired – April 25,2014) – Neuro-Biotech Corp. (OTC Pink: MRES) announced today that Effective Monday, April 28,2014, there will be a reverse split of 10 – 1 on MRES stock. also,Effective Monday, the corporate name of Neuro-Biotech Corp. will be changed to: The Institute of Biomedical Research Corp.

The Institute of Biomedical Research is an ambitious biomedical business venture whose activities extend from highly diversified scientific research and sophisticated services research and development, quality control and standardisation of pharmaceuticals, (cosmetics and food products) up to major long term biomedical and environmental research projects, as well as the development of new diagnostic technologies and innovative experimental medical treatments. Regulatory certification of new drugs and biomedical products also constitutes important business activities of the Institute. The Institute is essential for the development of Montenegro within the regional and European environment.

Dr. Drasko Pekovic, President of MRES, said, “These changes will enable the Institute to increase its international recognition  and  prosperous future, This is a large step forward in the further development of the Institute, and increased shareholder value. We are confident that these changes will have a positive effect moving forward, Our facilities are fully prepared to continue and expand its services throughout the European Union and beyond.”

[Back to Top]
 

Neuro-Biotech Corp. (MRES.PK) PERFORMS REVERSE MERGER WITH THE INSTITUTE OF BIOMEDICAL RESEARCH

PODGORCA, MONTENEGRO - February 10, 2014 - Neuro-Biotech Corp. (MRES:PK), announced today that it completed the acquisition of the Institute of Biomedical Research (the “Institute”), which is now a wholly-owned subsidiary of MRES.

The Institute of  BioMedical Research is a new biomedical ambitious business venture whose activities extend from highly diversified scientific research and sophisticated services research and development, quality control and standardisation of pharmaceuticals, cosmetics and food products) up to major long term biomedical and environmental research projects, as well as the development of new diagnostic technologies and innovative experimental medical treatments. Regulatory certification of new drugs and biomedical products also constitutes important business activities of the Institute. The Institute is essential for the development of Montenegro within the regional and European environment.

Dr. Drasko Pekovic, the new President of MRES, said “This transaction is a large step forward in the development of the Institute, and we envision that it will be instrumental in our forward progress.”

The transaction was achieved by the acquisition by MRES of all of the stock of the Institute in exchange for newly issued stock of MRES. The shareholders of the Institute, Dr. Drasko Pekovic and the Government of Montenegro, now hold majority control of MRES.

[Back to Top]
 

PUBLIC FINANCING

This is with proud and great pleasure to inform you that the Institute of BioMedical Research-Podgorica is now on one of the most prestigious stock markets in the world – the  OTC Markets.

This fabulous financial instrument is, without a doubt, one of the greatest tool ever invented for building wealth. The Institute is now on the road to financial freedom and on the most exciting pick of the skyrocketing business.

With the best regards,

Dr. Drasko Pekovic, Ph.D

President, CEO

To access information about the Institute on NYSE you may use following link:         http://www.otcmarkets.com/stock/MRES/company-info

 

[Back to Top]
 

Announcing the establishment of the Healthcare Industry Relations and Personalized Medicine Department

July 1st 2011, Montreal, Canada:

The Institute of BioMedical Research is pleased to announce the establishment of the Healthcare Industry Relations and Personalized Medicine Department.

“By launching our new department responsible for Healthcare Industry Relations and Personalized Medicine, we are creating our footprint in the domains of research projects targeting unmet medical needs and interventions with impact on quality of care in Montenegro” said Dr. Drasko Pekovic, President of the Institute of BioMedical Research.

“The new department will be managed initially out of our facilities in Montreal, Canada. Our core competencies will be created and developed under the leadership of Dr. Teodor Burtea, physician with more than 14 years of clinical and biopharmaceutical experience in Eastern Europe and Canada” continued Dr. Pekovic.

“Optimization of healthcare resources utilization through pharmacoeconomic evaluation, quality of care improvement initiatives and health technology interventions is a key strategic imperative for the Institute. Access to innovative medicines in Montenegro, which will prevent more significant illness and expense later, will facilitate appropriate response to the medical needs and evolving expectations of the society we serve.

We are looking forward to bringing on board professionals with the right expertise and exploring Public-Private partnerships in order to evolve from a quantitative healthcare delivery model to a personalized-care, based on quality outcomes” said Dr. Teodor Burtea.

[Back to Top]
 

Ongoing Studies

The Institute has recently proposed to the health authorities of the Government of Montenegro a project entitled: “Studies of mould-contaminated buildings and their impact on the public health.”

[Back to Top]
 

Job Opportunity

We are hiring

The Institute welcomes applications from all professionals around the world wishing to join our team.

Invitation to autonomous scientists

The Institute appreciates all applications from autonomous scientists wishing to develop their own scientific subject within the Institute.

[Back to Top]
 

Funds Raising Campaign of the Foundation for Biomedical Research “Sveti Vasilije Ostroski”

Working with donors and communities to raise funds to support the activities of the Institute of Biomedical Research-Podgorica, the “Sveti Vasilije Ostroski” foundation for Biomedical Research welcomes donations from every goodwill around the world.

You can help by donating to the foundation

The foundation awards all its grants to research projects identified by the scientific committee of the Institute which are aimed at the development of strategies, products and services to help improve the well-being and the quality of life of the population of Montenegro and surrounding regions.

Thank you for your kind consideration and generosity

[Back to Top]